// App-Quantinova.ai

: Adjuvant Systemic Therapy in High Risk Solitary Bone Plasmacytoma: Results of the UK Randomised Phase III IDRIS Study (CR UK/14/032)

Researchers

Presenter

  • Kushani Ediriwickrema

Principal Investigators

  • Neil K Rabin

  • Shirley D'Sa

  • Graham Jackson

  • Peter Hoskin

  • Eve Gallop-Evans

  • Patricia Díez

  • Catherine Parbutt

  • Andre Lopes

  • Sevasti Galani

  • Laura Clifton-Hadley

  • Darren Edwards

  • Husne Timur Tezver

  • Ruth M. de Tute

  • Andrew Bates

  • Roger G Owen

Medical Centers

  • Mount Vernon Hospital, London, GBR

  • St. James's University Hospital, Leeds, United Kingdom

  • Department of Haematology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • National Radiotherapy Trials Quality Assurance Group, Northwood, GBR

  • Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom

  • Velindre Cancer Centre, Cardiff, United Kingdom

  • Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom

  • St James' University Hospital, Leeds, GBR

  • Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Plasmacytoma

  • Coronavirus disease

Biomarkers

  • Sex hormone binding globulin

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

Outcome

  • N/A

Study Design

  • Randomized

  • Safety

  • Open Label

  • Multicenteric

  • Cross-Sectional

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved